|
HS Code |
861894 |
| Productname | Prim-O-Glucosylcimifugin |
| Casnumber | 23153-35-9 |
| Molecularformula | C21H28O10 |
| Molecularweight | 440.44 g/mol |
| Appearance | White to off-white powder |
| Purity | ≥98% (HPLC) |
| Solubility | Soluble in DMSO and methanol |
| Storagecondition | Store at -20°C, protect from light |
| Source | Extracted from Saposhnikovia divaricata (Fang Feng) |
| Chemicalclass | Cumarins (chromones) |
| Synonyms | Cimifugin-4'-O-β-D-glucoside |
| Iupacname | 6-(2'-O-β-D-glucopyranosyl)-cimifugin |
| Usage | Research on anti-inflammatory and analgesic properties |
| Meltingpoint | 215-218°C |
| Stability | Stable under recommended storage conditions |
As an accredited Prim-O-Glucosylcimifugin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Prim-O-Glucosylcimifugin is packaged in a sealed amber glass vial, labeled clearly, containing 100 mg of high-purity powder. |
| Shipping | Prim-O-Glucosylcimifugin is shipped in secure, airtight containers to ensure stability and prevent contamination. The packaging complies with chemical transport regulations, including labeling and safety documentation. For temperature-sensitive shipments, cold packs or refrigerated transport may be used to preserve the compound’s integrity during transit. Ensure immediate inspection upon receipt. |
| Storage | Prim-O-Glucosylcimifugin should be stored in a tightly sealed container, protected from light and moisture. Keep it at -20°C in a dry, well-ventilated area, away from incompatible substances. Avoid prolonged exposure to air. Ensure proper labeling and handle using standard laboratory precautions to maintain stability and prevent degradation. |
Competitive Prim-O-Glucosylcimifugin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Stepping into the facility, the scent of fresh raw materials and the hum of extraction lines tell a story backed by years of research and hands-on practice. The process of bringing Prim-O-Glucosylcimifugin from its botanical source to a highly refined product involves more than technical procedures—it asks for a deep respect for both the plant and the people who use the final material. Those who’ve handled raw Saposhnikovia divaricata know firsthand that subtle changes in climate, soil, and harvest timing press us to adapt and refine process parameters almost daily. The only way to manage that variation is through rigorous process control and precise analytics at every stage of extraction and purification. That’s what keeps every kilo of Prim-O-Glucosylcimifugin coming off the production line consistent, season after season.
The story begins with the raw root, often called Fang Feng in the field, carefully sourced and inspected at our facility before any processing starts. By controlling temperature and pressure right from the soaking stage, we make sure that the active glycosides retain their potency. Extraction solvents have to be selected based on both efficiency and environmental impact. Each batch runs through a sequence—filtration, concentration, and repeated chromatography—monitored by our own QA teams. A touch too much heat and you risk breaking the glucosidic bond that makes Prim-O-Glucosylcimifugin unique. Too little care during filtration and you’re left with excess plant residue, impacting downstream processes. The final crystalline product is not just an end-point, but a reflection of hundreds of small decisions made during manufacturing.
Prim-O-Glucosylcimifugin distinguishes itself through its unique molecular structure: a glycosylated chromone. Unlike common aglycone forms extracted from other traditional botanicals, the attached glucose group directly affects solubility and stability. This small difference translates into real-world results during formulation. As the main glucoside from Saposhnikovia divaricata, it often appears with other chromones like cimifugin and 4’-O-β-D-glucosyl-5-O-methylvisamminol—compounds that share biosynthetic roots but show noticeable differences in chromatographic purity, solubility, and taste profile. Customers often note the slightly sweet, almost neutral taste of Prim-O-Glucosylcimifugin compared to the pronounced bitterness of saposhnikonol-rich fractions.
In our plant, we track the full suite of chromones, though years of refining process flows have taught us that isolating Prim-O-Glucosylcimifugin demands more than standard ethanol extraction. The timing and sequence of solvent addition, as well as column conditions, must be tuned to optimize yield. Where other extracts end up with broad-spectrum mixtures, our material offers sharply defined purity—often tracking above 98%, verified batch-by-batch by HPLC. This purity means formulators can rely on highly predictable behavior in downstream processes, whether blending into granules, tablets, or topical creams.
Through direct experience, we’ve seen how fine particle size distribution supports rapid dispersion in aqueous systems—a lesson learned from trial after trial on tablet compression lines. Our Prim-O-Glucosylcimifugin follows a standardized model designation, always tied to the precise method used in extraction and post-processing. The common specification that buyers request is the crystalline form, typically standardized to greater than 98% content by HPLC, and matched to a narrow moisture range that prevents caking or clumping during storage. Granular flow properties see significant improvement due to our in-line milling and sieving operations. By the time material leaves the plant, every package is tested for ash content, heavy metals, pesticides, and microbial load—resulting in consistent compliance with both pharmacopeial and food supplement quality requirements.
Customers frequently ask why we invest so much into material screening and analytics rather than relying on supplier certificates. The experience of receiving a single batch out of spec—causing hours of downtime on a blending system—quickly underlines the cost of inconsistency. For this reason, every lot released has been through HPLC fingerprinting, UV-Vis quantitation, and full organoleptic evaluation. It takes investment in staff, equipment, and ongoing training, but our laboratory bench serves as the first and last line of defense in maintaining product reliability.
By working closely with formulators and researchers, we’ve built a detailed picture of where and how Prim-O-Glucosylcimifugin brings the greatest value. In traditional health supplements, especially those targeting joint comfort and seasonal immune function, the extract’s ease of use in both powder and tablet forms stands out. The improved water solubility compared to other chromone glycosides allows for clear, stable solutions that perform well in both cold and hot processing environments. Powder flow and compressibility remain highly manageable, which minimizes blend uniformity issues and supports high-speed direct compression.
In topical and cosmetic applications, formulators note the absence of gritty residues—a result of our strict control of final particle size and crystalline morphology. The extract blends smoothly with both hydrophilic and hydrophobic carriers. Early customers shared findings that poorly purified batches from other producers led to rapid instability and phase separation in emulsions. Years of feedback and collaborative adjustment to process parameters have taught our team to fine-tune not only the extraction but the drying and particle sizing steps, yielding a material that enhances stability and shelf life for finished formulations.
Many customers approach our team with questions about alternatives, such as cimifugin or holantol, which show up in similar botanical extracts. Through both bench work and scaled-up process trials, the differences become clear. Prim-O-Glucosylcimifugin’s glycosyl group delivers solubility in cold water systems that aglycone forms simply cannot match without aggressive carriers or surfactants. This means lower use of processing aids in granulation or beverage powders. The sweet, neutral flavor profile also contrasts with the metallic or bitter overtone of aglycone-rich extracts. From a technical perspective, our analytics teams appreciate the clear HPLC signature of Prim-O-Glucosylcimifugin, aiding rapid screening and minimizing the risk of mislabeling or adulteration.
Some third-party extracts depend on high-temperature, high-alcohol extractions that degrade key glycosides, leaving broader chromatographic peaks and often higher levels of residual solvents. Our process is built on continuous feedback—combining results from each batch with changes tracked in real time by both production and QC staff. This closed-loop control means only Prim-O-Glucosylcimifugin extracts that pass the strictest internal benchmarks move forward for final packaging. Years of customer use support the practical difference between properly purified Prim-O-Glucosylcimifugin and the mixed chromone extracts common in the market.
As a manufacturer, mistakes echo quickly through the supply chain, especially if a single day’s oversight leads to rework or discarded batches. We’ve learned to value rigorous supplier relationships and onsite audits at every upstream node—starting with contracted growers of Saposhnikovia divaricata. Quality programs enforce not only compliance with pesticide and heavy metal regulations but long-term improvement plans for soil and crop health. These relationships create a foundation for traceability, including GPS mapping of fields and continuous monitoring of post-harvest handling. Only with that level of transparency can we trust the raw material input flowing into each extraction run.
Moisture control gets special attention, since water content during storage or shipment can shift the product’s physical state and cause unwanted caking or microbial growth. After extraction, every lot is dried using low-temperature vacuum ovens, then transferred expeditiously to air-tight packaging. Batch records, kept both at-line and in our ERP system, create full backward and forward traceability. When customers report exceptional performance or detect an issue, that feedback flows straight to process engineering and quality assurance teams, closing the loop between production and use.
Continued collaboration with researchers and industry partners extends our understanding of Prim-O-Glucosylcimifugin into new applications. In recent years, we have worked alongside academic teams studying pharmacokinetics and absorption, noting the improved oral bioavailability thanks to the glycosyl moiety. University studies confirm the stability of the molecule in both simulated gastric and intestinal fluids, a property absent in some less refined extracts. These scientific results hold tangible meaning, providing material for papers and regulatory submissions around the world.
We also invest internally in method development—fine-tuning extraction steps, scaling up chromatography, and integrating new spectroscopy methods for faster, more reliable in-process control. Bench-scale trials move quickly into pilot and full-scale production, allowing rapid feedback and knowledge transfer across departments. This iterative approach, grounded in practical manufacturing experience, stands at the center of our commitment to supporting discovery without sacrificing product quality.
Working with botanically derived ingredients demands constant tracking of regulatory changes. We follow evolving standards from key markets, including pharmacopoeial monographs and food supplement regulations in the US, EU, and Asia-Pacific. Our internal compliance teams maintain documentation on each piece of the supply chain, certifying both traceability and safety. Each production batch undergoes testing for residual solvents, heavy metals, and pesticides to comply with strict local and global standards. Year-round, auditors from third-party agencies walk our production floor and inspect lab records.
Safety means more than hitting a number on a test report. From our side, this involves regular employee training sessions in handling, storage, and prevention of cross-contamination. Exposure to dust or fine particles is managed at the facility with dedicated air-handling and filtration systems, not just for staff health, but to ensure no cross-product contamination between runs. Allergen cross-reactivity and stability through the product’s shelf life are evaluated using both in-house and external accredited laboratories.
The plant-derived nature of Prim-O-Glucosylcimifugin brings both opportunities and persistent challenges. Cropping weather, soil fluctuations, and subtle shifts in plant biochemistry require constant adaptation. That has driven us to invest in analytical flexibility, making sure QA and R&D teams share knowledge rapidly. A spike in plant saponin content, for example, can make extraction less efficient and requires fast changes to solvent profile and process time without risking batch quality. This responsiveness grows out of decades spent troubleshooting on the plant floor—learning directly from both successes and setbacks.
The final product’s stability, a point of frequent feedback, draws scrutiny from both new and established customers. UV exposure, residual moisture, and storage temperature all impact the shelf life and aesthetic qualities of crystalline Prim-O-Glucosylcimifugin. Our learning here has come through extensive stress testing and tracking delivered shipments over time. Double-layered packaging with desiccant packs, rapid transition from production to cold storage, and regular shelf tests in real-world transport conditions stand at the core of our packaging protocols.
Managing the environmental footprint of extraction operations motivates daily improvement. While solvent-based extraction remains standard, our process engineering team continues to evaluate and implement greener approaches, minimizing waste and solvent emissions through continuous recycling and in-house treatment systems. Recovered solvents are tracked through mass balance and scrubbed for contaminants before being sent for further processing or recovery. This focus aims to ensure both regulatory compliance and stewardship of limited natural resources.
Our roots in direct manufacturing keep us closely attuned to the impact of each operation—whether through the careful sourcing of botanical raw material or the wastewater generated on site. We work with local and regional environmental groups to implement field conservation practices, fostering sustainable crop cycles for Saposhnikovia divaricata. By connecting process improvements with ecological monitoring, we move steadily toward a production cycle that serves both customers and the wider environment.
Trust grows in the factory long before it reaches the marketplace. Meetings between process engineers, operators, and the quality team often surface small improvements—adjusting a filtration step, recalibrating a detector, or enhancing batch documentation. Each improvement reduces risk of deviation, strengthens process robustness, and protects both us and our customers from uncertainty. As new partners visit the plant and inspect records, they see a living system—one built on shared expertise, honest communication, and a continuous pursuit of higher standards for Prim-O-Glucosylcimifugin.
Years of hands-on work show that the final material reflects every link in the chain. From the grower’s field through the extraction column, purification, analytics, packaging, and shipping, each step calls for vigilance and care. Customers count on us to deliver not only reliable quality but the depth of insight that comes only from direct manufacturing experience. This is the perspective that shapes every decision on our production line—a commitment to measurable, repeatable quality that builds trust batch after batch.